KKR vs WST · P/E 33, rev $10.04B vs P/E 35, rev $1.72B
KKR & Co. Inc. (KKR) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
KKR & Co. Inc. (KKR) is a asset management company listed on NYSE.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported KKR revenue for 2026-06-30 was $10.04B. Net income was $1.11B. KKR currently screens at market cap $90.61B and trailing P/E 33.1.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
KKR currently screens at market cap $90.61B and trailing P/E 33.1. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the KKR and WST stock pages for the full models.
Not investment advice.